Pharmaceuticals & Congress

Is Congress Protecting Drug Makers? The former head of the DEA office what was responsible for preventing prescription medicine abuse, said that drug companies and their lobbyists have a “stranglehold” on Congress that protects the 9 billion dollar a year trade in opioid painkillers. Joseph Rannazzisi, who held his position with the DEA until a year ago,…

Alternatives to Opioid Painkillers on the Horizon

Due to continued and growing concern about the opioid epidemic, scientists are now trying to create an opioid painkiller that relieves pain without triggering the euphoria, dependence, and respiratory suppression that causes overdoses. It is too common of a story that patients who are prescribed opiate pain medications for legitimate pain report becoming addicted to…

New Implant for Treating Opioid Addiction

A panel of medical experts recommended in January 2016 that the Food and Drug Administration approve a new way of treating opiate addiction and on May 26, 2016, the FDA announced approval for the first buprenorphine implant for the treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for…